Puma Biotechnology, Inc.

Yield per half year: +69.86%
Dividend yield: 0%
Sector: Healthcare

Fair price Puma Biotechnology, Inc.

Current price
5.86 $
Average price
2.58 $ -56.04%

Price based on EPS
4.87 $ -16.81%
0/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 4.87 $
Current price = 5.86 $ (difference = -16.81%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = βˆ‘ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 24.62 $
Current price = 5.86 $ (difference = +320.06%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = βˆ‘ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 18.96 $
Current price = 5.86 $ (difference = +223.47%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription